Volume 24, Issue 3
Research Article

Explained randomness in proportional hazards models

Ronghui Xu

Corresponding Author

E-mail address: rxu@jimmy.harvard.edu

Department of Biostatistics, Harvard School of Public Health and Dana‐Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, U.S.A.

Department of Biostatistics, Harvard School of Public Health and Dana‐Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, U.S.A.Search for more papers by this author
Janez Stare

E-mail address: janez.stare@mf.uni‐lj.si

Department of Biomedical Informatics, School of Medicine, University of Ljubljana, Slovenia

Search for more papers by this author
First published: 08 November 2004
Citations: 82

Abstract

A coefficient of explained randomness, analogous to explained variation but for non‐linear models, was presented by Kent. The construct hinges upon the notion of Kullback–Leibler information gain. Kent and O'Quigley developed these ideas, obtaining simple, multiple and partial coefficients for the situation of proportional hazards regression. Their approach was based upon the idea of transforming a general proportional hazards model to a specific one of Weibull form. Xu and O'Quigley developed a more direct approach, more in harmony with the semi‐parametric nature of the proportional hazards model thereby simplifying inference and allowing, for instance, the use of time dependent covariates. A potential drawback to the coefficient of Xu and O'Quigley is its interpretation as explained randomness in the covariate given time. An investigator might feel that the interpretation of the Kent and O'Quigley coefficient, as a proportion of explained randomness of time given the covariate, is preferable. One purpose of this note is to indicate that, under an independent censoring assumption, the two population coefficients coincide. Thus the simpler inferential setting for Xu and O'Quigley can also be applied to the coefficient of Kent and O'Quigley. Our second purpose is to point out that a sample‐based coefficient in common use in the SAS statistical package can be interpreted as an estimate of explained randomness when there is no censoring. When there is censoring the SAS coefficient would not seem satisfactory in that its population counterpart depends on an independent censoring mechanism. However there is a quick fix and we argue in favour of its use. Copyright © 2004 John Wiley & Sons, Ltd.

Number of times cited according to CrossRef: 82

  • Evidence-based Tumor Staging of Skeletal Chondrosarcoma, The American Journal of Surgical Pathology, 10.1097/PAS.0000000000001397, 44, 1, (111-119), (2020).
  • Key determinants and heterogeneous frailties in passenger loyalty toward customized buses: An empirical investigation of the subscription termination hazard of users, Transportation Research Part C: Emerging Technologies, 10.1016/j.trc.2020.102636, 115, (102636), (2020).
  • Comparison of Systemic EBV-positive T-Cell and NK-Cell Lymphoproliferative Diseases of Childhood Based on Classification Evolution, American Journal of Surgical Pathology, 10.1097/PAS.0000000000001495, 44, 8, (1061-1072), (2020).
  • Calculating the sample size required for developing a clinical prediction model, BMJ, 10.1136/bmj.m441, (m441), (2020).
  • Quantifying the Predictive Accuracy of a Polygenic Risk Score for Predicting Incident Cancer Cases : Application to the CARTaGENE Cohort, Frontiers in Genetics, 10.3389/fgene.2020.00408, 11, (2020).
  • Unified methods for feature selection in large-scale genomic studies with censored survival outcomes, Bioinformatics, 10.1093/bioinformatics/btaa161, (2020).
  • Staging soft tissue sarcoma of the head and neck: Evaluation of the AJCC 8th edition revised T classifications, Head & Neck, 10.1002/hed.25701, 41, 7, (2359-2366), (2019).
  • Body mass index in early pregnancy and future risk of severe liver disease: a population‐based cohort study, Alimentary Pharmacology & Therapeutics, 10.1111/apt.15162, 49, 6, (789-796), (2019).
  • Chromosome errors in human eggs shape natural fertility over reproductive life span, Science, 10.1126/science.aav7321, 365, 6460, (1466-1469), (2019).
  • Multiparametric approach to congestion for predicting long-term survival in heart failure, Journal of Cardiology, 10.1016/j.jjcc.2019.05.017, (2019).
  • Intrinsic traits of woodland caribou Rangifer tarandus caribou calves depredated by black bears Ursus americanus and coyotes Canis latrans, Wildlife Biology, 10.2981/wlb.00494, 2019, 1, (2019).
  • The uncertainty with using risk prediction models for individual decision making: an exemplar cohort study examining the prediction of cardiovascular disease in English primary care, BMC Medicine, 10.1186/s12916-019-1368-8, 17, 1, (2019).
  • Claims-Based Approach to Predict Cause-Specific Survival in Men With Prostate Cancer, JCO Clinical Cancer Informatics, 10.1200/CCI.18.00111, 3, (1-7), (2019).
  • Survival outcome patterns revealed by deploying advanced tags in quantity: Pacific halibut ( Hippoglossus stenolepis ) survivals after release from trawl catches through expedited sorting , Canadian Journal of Fisheries and Aquatic Sciences, 10.1139/cjfas-2018-0350, (1-10), (2019).
  • A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis, Leukemia, 10.1038/s41375-018-0196-8, 33, 1, (159-170), (2018).
  • Minimum sample size for developing a multivariable prediction model: PART II ‐ binary and time‐to‐event outcomes, Statistics in Medicine, 10.1002/sim.7992, 38, 7, (1276-1296), (2018).
  • Comprehensive Analysis of the Neutrophil-to-Lymphocyte Ratio for Preoperative Prognostic Prediction Nomogram in Gastric Cancer, World Journal of Surgery, 10.1007/s00268-018-4510-4, 42, 8, (2530-2541), (2018).
  • Discrimination measures for discrete time-to-event predictions, Econometrics and Statistics, 10.1016/j.ecosta.2017.03.008, 7, (153-164), (2018).
  • Predation risk for boreal woodland caribou in human-modified landscapes: Evidence of wolf spatial responses independent of apparent competition, Biological Conservation, 10.1016/j.biocon.2018.09.015, 228, (215-223), (2018).
  • Prediction of acute myeloid leukaemia risk in healthy individuals, Nature, 10.1038/s41586-018-0317-6, 559, 7714, (400-404), (2018).
  • Three‐month posttreatment prostate‐specific antigen level as a biomarker of treatment response in patients with intermediate‐risk or high‐risk prostate cancer treated with androgen deprivation therapy and radiotherapy, Cancer, 10.1002/cncr.31400, 124, 14, (2939-2947), (2018).
  • Simple staging system for osteosarcoma performs equivalently to the AJCC and MSTS systems, Journal of Orthopaedic Research, 10.1002/jor.24032, 36, 10, (2802-2808), (2018).
  • Body Composition and Mortality in Mexican American Adults: Results from the National Health and Nutrition Examination Survey, Obesity, 10.1002/oby.22251, 26, 8, (1372-1380), (2018).
  • A high‐quality pedigree and genetic markers both reveal inbreeding depression for quality but not survival in a cooperative mammal, Molecular Ecology, 10.1111/mec.14570, 27, 9, (2271-2288), (2018).
  • Exploration of DNA methylation markers for diagnosis and prognosis of patients with endometrial cancer, Epigenetics, 10.1080/15592294.2018.1474071, 13, 5, (490-504), (2018).
  • Explained Variation for Survival Models, The Stata Journal: Promoting communications on statistics and Stata, 10.1177/1536867X0600600105, 6, 1, (83-96), (2018).
  • The Vanderbilt staging system for retroperitoneal sarcoma: a validation study of 6857 patients from the National Cancer Database, Modern Pathology, 10.1038/s41379-018-0166-8, (2018).
  • Prediction Accuracy Measures for a Nonlinear Model and for Right-Censored Time-to-Event Data, Journal of the American Statistical Association, 10.1080/01621459.2018.1515079, (1-17), (2018).
  • Prediction errors for state occupation and transition probabilities in multi‐state models, Biometrical Journal, 10.1002/bimj.201600191, 60, 1, (34-48), (2017).
  • Explained variation in shared frailty models, Statistics in Medicine, 10.1002/sim.7592, 37, 9, (1482-1490), (2017).
  • Effects of climate and fine particulate matter on hospitalizations and deaths for heart failure in elderly: A population-based cohort study, Environment International, 10.1016/j.envint.2017.06.001, 106, (257-266), (2017).
  • Performance Analysis of the American Joint Committee on Cancer 8th Edition Staging System for Retroperitoneal Sarcoma and Development of a New Staging Algorithm for Sarcoma-Specific Survival, Annals of Surgical Oncology, 10.1245/s10434-017-6116-8, 24, 13, (3880-3887), (2017).
  • Comparison of the AJCC, MSTS, and Modified Spanier Systems for Clinical and Pathologic Staging of Osteosarcoma, The American Journal of Surgical Pathology, 10.1097/PAS.0000000000000774, 41, 3, (405-413), (2017).
  • Clinical outcomes and survival surrogacy studies of prostate‐specific antigen declines following enzalutamide in men with metastatic castration‐resistant prostate cancer previously treated with docetaxel, Cancer, 10.1002/cncr.30587, 123, 12, (2303-2311), (2017).
  • Breeding decisions and output are correlated with both temperature and rainfall in an arid-region passerine, the sociable weaver, Royal Society Open Science, 10.1098/rsos.170835, 4, 9, (170835), (2017).
  • Climate change can alter predator–prey dynamics and population viability of prey, Oecologia, 10.1007/s00442-017-4017-y, (2017).
  • Three measures of explained variation for correlated survival data under the proportional hazards mixed‐effects model, Statistics in Medicine, 10.1002/sim.6993, 35, 23, (4153-4165), (2016).
  • Explained Variation for Correlated Survival Data Under the Proportional Hazards Mixed-Effects Model, Statistical Applications from Clinical Trials and Personalized Medicine to Finance and Business Analytics, 10.1007/978-3-319-42568-9_14, (165-177), (2016).
  • Boosting the discriminatory power of sparse survival models via optimization of the concordance index and stability selection, BMC Bioinformatics, 10.1186/s12859-016-1149-8, 17, 1, (2016).
  • Adequate sample size for developing prediction models is not simply related to events per variable, Journal of Clinical Epidemiology, 10.1016/j.jclinepi.2016.02.031, 76, (175-182), (2016).
  • Predictive accuracy of novel risk factors and markers: A simulation study of the sensitivity of different performance measures for the Cox proportional hazards regression model, Statistical Methods in Medical Research, 10.1177/0962280214567141, 26, 3, (1053-1077), (2015).
  • Sample size considerations for the external validation of a multivariable prognostic model: a resampling study, Statistics in Medicine, 10.1002/sim.6787, 35, 2, (214-226), (2015).
  • A note on bias of measures of explained variation for survival data, Statistics in Medicine, 10.1002/sim.6749, 35, 6, (877-882), (2015).
  • Exploring the Clustering Effect of the Frailty Survival Model by Means of the Brier Score, Communications in Statistics - Simulation and Computation, 10.1080/03610918.2014.936464, 45, 9, (3294-3306), (2015).
  • Using a latent class model to refine risk stratification in multiple myeloma, Statistics in Medicine, 10.1002/sim.6557, 34, 21, (2971-2980), (2015).
  • Explained variation for recurrent event data, Biometrical Journal, 10.1002/bimj.201300143, 57, 4, (571-591), (2015).
  • Impact of Bariatric Surgery on Life Expectancy in Severely Obese Patients With Diabetes, Annals of Surgery, 10.1097/SLA.0000000000000907, 261, 5, (914-919), (2015).
  • Assessing potentially time‐dependent treatment effect from clinical trials and observational studies for survival data, with applications to the Women's Health Initiative combined hormone therapy trial, Statistics in Medicine, 10.1002/sim.6453, 34, 11, (1801-1817), (2015).
  • Cox Proportional Hazards Regression Model, Regression Modeling Strategies, 10.1007/978-3-319-19425-7_20, (475-519), (2015).
  • A Comorbidity Index for Mortality Prediction in Chinese Patients with ESRD Receiving Hemodialysis, Clinical Journal of the American Society of Nephrology, 10.2215/CJN.03100313, 9, 3, (513-519), (2013).
  • A discrimination index for selecting markers of tumor growth dynamic across multiple cancer studies with a cure fraction, Genomics, 10.1016/j.ygeno.2013.02.013, 102, 2, (102-111), (2013).
  • Predictors of outcome in outpatients with anxiety disorders: The Leiden routine outcome monitoring study, Journal of Psychiatric Research, 10.1016/j.jpsychires.2013.09.005, 47, 12, (1876-1885), (2013).
  • Competing risks for train tickets – An empirical investigation of customer behavior and performance in the railway industry, Transportation Research Part E: Logistics and Transportation Review, 10.1016/j.tre.2012.12.005, 51, (1-16), (2013).
  • A comparison of estimators to evaluate the discriminatory power of time‐to‐event models, Statistics in Medicine, 10.1002/sim.5464, 31, 23, (2588-2609), (2012).
  • A simulation study of predictive ability measures in a survival model II: explained randomness and predictive accuracy, Statistics in Medicine, 10.1002/sim.5460, 31, 23, (2644-2659), (2012).
  • Child-Turcotte score versus MELD for prognosis in a randomized controlled trial of emergency treatment of bleeding esophageal varices in cirrhosis, Journal of Surgical Research, 10.1016/j.jss.2012.01.004, 178, 1, (139-146), (2012).
  • Relationship between diabetes risk and admixture in postmenopausal African-American and Hispanic-American women, Diabetologia, 10.1007/s00125-012-2486-4, 55, 5, (1329-1337), (2012).
  • Knowledge Seeking and Outward FDI of Emerging Market Firms: The Moderating Effect of Inward FDI, SSRN Electronic Journal, 10.2139/ssrn.2046753, (2012).
  • Vertical T cell immunodominance and epitope entropy determine HIV-1 escape, Journal of Clinical Investigation, 10.1172/JCI65330, (2012).
  • A simulation study of predictive ability measures in a survival model I: Explained variation measures, Statistics in Medicine, 10.1002/sim.4242, 31, 23, (2627-2643), (2011).
  • A measure of explained risk in the proportional hazards model, Biostatistics, 10.1093/biostatistics/kxr047, 13, 2, (315-325), (2011).
  • Co-morbidity between major depressive disorder and anxiety disorders: shared etiology or direct causation?, Psychological Medicine, 10.1017/S0033291711000407, 41, 10, (2023-2034), (2011).
  • Risk Factors for Onset of Disability Among Older Persons Newly Diagnosed With Heart Failure: The Cardiovascular Health Study, Journal of Cardiac Failure, 10.1016/j.cardfail.2011.04.015, 17, 9, (764-770), (2011).
  • A pseudo-R2measure for selecting genomic markers with crossing hazards functions, BMC Medical Research Methodology, 10.1186/1471-2288-11-28, 11, 1, (2011).
  • References, Dynamic Prediction in Clinical Survival Analysis, 10.1201/b11311-21, (217-231), (2011).
  • References, Applied Survival Analysis, undefined, (365-381), (2011).
  • An information-theoretic approach to surrogate-marker evaluation with failure time endpoints, Lifetime Data Analysis, 10.1007/s10985-010-9185-6, 17, 2, (195-214), (2010).
  • A Robust Alternative to the Schemper–Henderson Estimator of Prediction Error, Biometrics, 10.1111/j.1541-0420.2010.01459.x, 67, 2, (524-535), (2010).
  • A Measure of Explained Variation for Event History Data, Biometrics, 10.1111/j.1541-0420.2010.01526.x, 67, 3, (750-759), (2010).
  • Association of longitudinal measures of hemoglobin and outcomes after hospitalization for heart failure, American Heart Journal, 10.1016/j.ahj.2009.10.029, 159, 1, (81-89), (2010).
  • Identifying common prognostic factors in genomic cancer studies: A novel index for censored outcomes, BMC Bioinformatics, 10.1186/1471-2105-11-150, 11, 1, (2010).
  • On the Prognostic Value of Gene Expression Signatures for Censored Data, Advances in Data Analysis, Data Handling and Business Intelligence, 10.1007/978-3-642-01044-6_61, (663-673), (2010).
  • On the prognostic value of survival models with application to gene expression signatures, Statistics in Medicine, 10.1002/sim.3768, 29, 7‐8, (818-829), (2010).
  • Evaluation of Human Immunodeficiency Virus Biomarkers, Epidemiology, 10.1097/EDE.0b013e3181a71519, 20, 5, (664-672), (2009).
  • Combining estimates of interest in prognostic modelling studies after multiple imputation: current practice and guidelines, BMC Medical Research Methodology, 10.1186/1471-2288-9-57, 9, 1, (2009).
  • The Concordance Index C and the Mann–Whitney Parameter Pr(X>Y) with Randomly Censored Data, Biometrical Journal, 10.1002/bimj.200800228, 51, 3, (467-474), (2009).
  • Prostate-Specific Antigen Progression Predicts Overall Survival in Patients With Metastatic Prostate Cancer: Data from Southwest Oncology Group Trials 9346 (Intergroup Study 0162) and 9916, Journal of Clinical Oncology, 10.1200/JCO.2008.19.9810, 27, 15, (2450-2456), (2009).
  • Measures to assess the prognostic ability of the stratified Cox proportional hazards model, Statistics in Medicine, 10.1002/sim.3378, 28, 3, (389-411), (2008).
  • Comparative optimism in models involving both classical clinical and gene expression information, BMC Bioinformatics, 10.1186/1471-2105-9-434, 9, 1, (2008).
  • A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1, Blood, 10.1182/blood-2006-07-038430, 109, 6, (2276-2284), (2006).
  • Quantification of the Prentice Criteria for Surrogate Endpoints, Biometrics, 10.1111/j.1541-0420.2006.00538.x, 62, 1, (297-300), (2006).
  • Explained variation under the additive hazards model, Statistics in Medicine, 10.1002/sim.8763, 0, 0, (undefined).

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.